TCL Archive In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor February 14, 1992
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983